US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on September 16, 2026

Sep. 16, 2026

VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs

Indeterminate GlobeNewswire

Sep. 16, 2026

RIX Industries Partners with Build Health International to Bring Medical Oxygen Compressor Training to Africa

Indeterminate GlobeNewswire

Sep. 16, 2026

Rezera Announces Plans to Launch the REVEAL-PAD Multi-Center Study Investigating the Role of Inflammation in Patients with Peripheral Artery Disease

Indeterminate GlobeNewswire

Sep. 16, 2026

Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum

Indeterminate GlobeNewswire

Sep. 16, 2026

R1 Expands Phare OS with Phare UM, Bringing Real-Time Payer Risk Intelligence to Utilization Management

Indeterminate GlobeNewswire

Sep. 16, 2026

Syneos Health and Tufts CSDD Study Shows Clinical Trial Performance Depends More on Operating Model Design Than Sourcing Strategy

Indeterminate GlobeNewswire

Sep. 16, 2026

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

Indeterminate GlobeNewswire

Sep. 16, 2026

Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division

Indeterminate GlobeNewswire

Sep. 16, 2026

Shock Top and Spirit Halloween Brew Up a Scary Good Collaboration

Indeterminate GlobeNewswire

Sep. 16, 2026

NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference

Indeterminate GlobeNewswire

Sep. 16, 2026

Kailera Therapeutics to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 16, 2026

AAVantgarde to Showcase Clinical Progress in Usher 1B and Stargardt Disease at EURetina 2026

Indeterminate GlobeNewswire

Sep. 16, 2026

Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026

Indeterminate GlobeNewswire

Sep. 16, 2026

RIX Industries Partners with Build Health International to Bring Medical Oxygen Compressor Training to Africa

Indeterminate GlobeNewswire

Sep. 16, 2026

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease

Indeterminate GlobeNewswire

Sep. 16, 2026

חברת RIX Industries משתפת פעולה עם Build Health International כדי להביא לאפריקה הכשרה בנושא מדחסי חמצן רפואיים

Indeterminate GlobeNewswire

Sep. 16, 2026

Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire